BMO Capital analyst Kelly Bania downgrades Dollar Gen (NYSE:DG) from Outperform to Market Perform.
BMO Capital Downgrades Dollar Gen to Market Perform
BMO Capital analyst Kelly Bania downgrades Dollar Gen (NYSE:DG) from Outperform to Market Perform.
Related Posts
Truist Securities Maintains Buy on Ameris, Raises Price Target to $60
Truist Securities analyst Jennifer Demba maintains Ameris (NASDAQ:ABCB) with a Buy and raises the price target from $55 to $60.
What 3 FibroGen Analysts Are Expecting From Thursday’s Roxadustat Adcom Verdict
FibroGen, Inc. (NASDAQ: FGEN) has a key catalyst Thursday when FDA's Cardiovascular and Renal Drugs Advisory Committee will issue its recommendation on the company's new drug application for roxadustat.
The committee is scheduled to meet between 9:30 a.m. and 5:30 p.m.
Scotiabank Downgrades Braskem to Sector Underperform
Scotiabank analyst Ben Isaacson downgrades Braskem (NYSE:BAK) from Sector Perform to Sector Underperform.